Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complex

Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complex

Abstract Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) drives viral B cell transformation and oncogenesis. LMP1’s transforming activity depends on its C-terminal activation region 2 (CTAR2), which induces NF-κB and JNK by engaging TNF receptor-associated factor 6 (TRAF6). The mechanism o...

Full description

Bibliographic Details
Main Authors:	Fabian Giehler, Michael S. Ostertag, Thomas Sommermann, Daniel Weidl, Kai R. Sterz, Helmut Kutz, Andreas Moosmann, Stephan M. Feller, Arie Geerlof, Brigitte Biesinger, Grzegorz M. Popowicz, Johannes Kirchmair, Arnd Kieser
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-01-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-023-44455-w

Similar Items

TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
by: Hannah Greenfeld, et al.
Published: (2015-05-01)

Proteomic identification of the tyrosine phosphatase SHP1 as a novel LMP1 interaction partner, which mediates autoregulation of LMP1 signaling
by: Kieser A, et al.
Published: (2009-02-01)

Epstein-Barr Virus LMP1 Modulates the CD63 Interactome
by: Mujeeb Cheerathodi, et al.
Published: (2021-04-01)

Transcriptome Changes Induced by Epstein-Barr Virus LMP1 and LMP2A in Transgenic Lymphocytes and Lymphoma
by: Kathy H. Y. Shair, et al.
Published: (2012-11-01)

The viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity.
by: Frank Schneider, et al.
Published: (2008-01-01)

Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition
by: Wilson Joanna B, et al.
Published: (2010-07-01)

Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.
by: Alexandra C Vrazo, et al.
Published: (2012-01-01)

Phylodynamic characteristics of the LMP-1 gene of the Epstein–Barr virus isolated in the Nizhny Novgorod region
by: Daria A. Bryzgalova, et al.
Published: (2023-11-01)

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
by: Kina Kase, et al.
Published: (2021-03-01)

Epstein–Barr virus in the ethnic Tatars population: the infection and sequence variants of LMP1 oncogene
by: K. V. Smirnova, et al.
Published: (2018-11-01)

The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.
by: Anna Shkoda, et al.
Published: (2012-01-01)

PRESENCIA DEL MARCADOR LMP-1 DEL VIRUS EPSTEIN-BARR EN LINFOMAS DE CANINOS
by: L. C. Veloza, et al.
Published: (2017-01-01)

Hubungan virus Epstein Barr dengan penyakit hodgkin :: Suatu analisis imunohistopatologik ekspresi EBV LMP-1
by: , MURTONO, C, et al.
Published: (1996)

Hubungan virus Epstein Barr dengan penyakit hodgkin :: Suatu analisis imunohistopatologik ekspresi EBV LMP-1
by: , MURTONO, C, et al.
Published: (1996)

Identification and characterization of a novel Epstein-Barr Virus-encoded circular RNA from LMP-2 Gene
by: Ke-En Tan, et al.
Published: (2021-07-01)

Changes in Expression Induced by Epstein-Barr Virus LMP1-CTAR1: Potential Role of bcl3
by: Rachel Hood Edwards, et al.
Published: (2015-05-01)

PERAN PROTEIN ABNA1, EBNA2, LMP1 DAN LMP2 VIRUS EPSTEIN BARR SEBAGAI FAKTOR PROGNOSIS PADA PENGOBATAN KARSINOMA NASOFARINGS
by: , BAMBANG HARIWIYANTO
Published: (2009)

Peran protein EBNA1, EBNA2, LMP1 dan LMP2 virus Epstein-Barr sebagai faktor prognosis pada pengobatan karsinoma nasofarings
by: , HARIWIYANTO, Bambang, et al.
Published: (2009)

Hubungan antara virus Epstein Barr dengan penyakit Hodgkin. Suatu analisis imunohistopatologik ekspresi EBV LMP-1.
by: Perpustakaan UGM, i-lib
Published: (1997)

Serum Anti-Zta and Anti-LMP1 Antibodies in Oropharyngeal Cancer Related to Epstein–Barr Virus—Diagnostic Usefulness
by: Anna Polz, et al.
Published: (2024-01-01)

Distribution of Epstein–Barr Virus LMP1 Variants in Patients with Infectious Mononucleosis and Association with Selected Biochemical and Hematological Parameters
by: Snjezana Zidovec-Lepej, et al.
Published: (2023-07-01)

Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein–Barr Virus LMP1 Protein
by: Abdelhalim Khenchouche, et al.
Published: (2023-06-01)

Epstein-Barr virus in Adygeans and Slavs in Russia: virus types, <i>LMP1</i> variants, and malignant tumors
by: K. V. Smirnova, et al.
Published: (2022-10-01)

Efficient Epstein-Barr Virus Progeny Production Mediated by Cancer-Derived LMP1 and Virally-Encoded microRNAs
by: Misako Yajima, et al.
Published: (2019-04-01)

Epstein-Barr virus LMP1 manipulates the content and functions of extracellular vesicles to enhance metastatic potential of recipient cells.
by: Dingani Nkosi, et al.
Published: (2020-12-01)

Characterization of target gene regulation by the two Epstein-Barr virus oncogene LMP1 domains essential for B-cell transformation
by: Bidisha Mitra, et al.
Published: (2023-12-01)

A Systematic Review of Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
by: Ana Banko, et al.
Published: (2021-08-01)

Epstein–Barr virus LMP1 oncogene polymorphism in tatar and slavic populations in Russian Federation impacting on some malignant tumours
by: V. E. Gurtsevitch, et al.
Published: (2020-05-01)

Upregulation of Id1 by Epstein-Barr Virus-encoded LMP1 confers resistance to TGFβ-mediated growth inhibition
by: Yu Yanxing, et al.
Published: (2010-06-01)

Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.
by: Pok Man Hau, et al.
Published: (2011-01-01)

CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth
by: Haifeng Huo, et al.
Published: (2019-10-01)

The role of the TRAF2/3 binding site in LMP1 and CD40 signaling
by: Bishop GA, et al.
Published: (2009-06-01)

Interleukins, laminin and epstein - barr virus latent membrane protein 1 (EBV LMP1) Promote metastatic phenotype in nasopharyngeal carcinoma
by: Khoo Alan SB, et al.
Published: (2010-10-01)

Generation and Characterization of a Novel Recombinant Antibody against LMP1-TES1 of Epstein-Barr Virus Isolated by Phage Display
by: Jin Zhu, et al.
Published: (2013-04-01)

CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signals.
by: Mayumi Yoshimori, et al.
Published: (2014-01-01)

Variansi sekuen gen penyandi C terminus latent membrane protein 1 (LMP-1) epstein-barr virus penderita karsinoma nasofaring
by: , HARYANTO, Aris, et al.
Published: (1999)

Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.
by: Rajesh Ramakrishnan, et al.
Published: (2011-01-01)

C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes
by: E. Kobayashi, et al.
Published: (2018-02-01)

Modulation of LMP2A Expression by a Newly Identified Epstein-Barr Virus-Encoded MicroRNA miR-BART22
by: Raymond Wai-Ming Lung, et al.
Published: (2009-11-01)

LMP1 and 2A Induce the Expression of Nrf2 Through Akt Signaling Pathway in Epstein-Barr Virus–Transformed B Cells
by: Sun-mi Yun, et al.
Published: (2019-05-01)